CG200745 PPA

CG200745 PPA · CrystalGenomics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CG200745 PPA, covering 2023-09-13 to 2023-09-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of CG200745 PPA for Myelodysplastic Syndrome [Phase 1, Phase 2]